Augur Signals: News Feed

Report Archive – September 2025

Augur Signals: News Feed
Biotechnology , Healthcare , Alert

PepGen Inc.: RA Capital Management, L.P. Buys $47.53M in Shares

  • Acquired: Non-Derivative
PepGen Inc.: RA Capital Management, L.P. Buys $47.53M in Shares
RA Capital Management, L.P., a significant stakeholder and director, purchased shares in PepGen Inc. valued at $47.53 million on September 26, 2025. This acquisition increased their shareholding by 1.02%, totaling 18,554,273 shares. Despite PepGen Inc.'s negative valuation ratios indicating unprofitability, technical indicators suggest bullish momentum with a potential price rise to 5.50. However, high volatility presents risks, with a potential decrease to 4.20. The transaction was conducted on the NMS exchange under the ticker PEPG.
Asset Management , Financial Services , Alert

MSC Income Fund, Inc.: Insider Magdol David L. Buys $47,005 Worth of Stock

  • Acquired: Non-Derivative
MSC Income Fund, Inc.: Insider Magdol David L. Buys $47,005 Worth of Stock

On September 30, 2025, Magdol David L., a key figure at MSC Income Fund, Inc., purchased shares worth $47,005, increasing his stake by 8.31%. With a history of 543 transactions and a 67% ROI, his actions reflect strong confidence in the company. MSC Income Fund shows a higher P/E ratio, suggesting potential undervaluation, despite recent market dips. Low RSI and insider buying indicate possible upward momentum, with predictions of the stock reaching 13.75 short-term and 14.25 mid-term. However, caution is advised due to negative MACD and market volatility.

Asset Management , Financial Services , Alert

Gabelli Global Small and Mid Cap Value Trust: Mario J Gabelli Executes $15.2M Transaction

  • Acquired: Non-Derivative
Gabelli Global Small and Mid Cap Value Trust: Mario J Gabelli Executes $15.2M Transaction

On September 26, 2025, Mario J Gabelli, a Director and 10%+ Owner of The Gabelli Global Small and Mid Cap Value Trust (GGZ), executed a transaction worth $15.2 million. This increased his shares to 1,050,000, indicating confidence in the company's prospects. With a P/E ratio of 5.03, GGZ appears undervalued, with recent trades stabilizing at $14.48. Predicted prices suggest minor gains, with expectations to reach $15.2 in four weeks. The insider's history of profitable trades and significant purchase suggest potential bullish momentum.

Real Estate Services , Real Estate , Alert

Opendoor Technologies Inc.: Eric Wu's $2.65M Transaction Signals Strategic Move

  • Acquired: Non-Derivative
Opendoor Technologies Inc.: Eric Wu's $2.65M Transaction Signals Strategic Move
Eric Wu, a Director at Opendoor Technologies Inc., executed an insider transaction worth $2.65 million on September 26, 2025, increasing his holdings by 18.23%. His trades, historically outperforming the market, reflect confidence in Opendoor's future. Opendoor's Forward P/E is -30.37, with a Price to Sales ratio of 1.17. The recent closing price was $8.81, with a short-term target of $9.00. Despite potential upward momentum, a high Price to Book ratio suggests a risk of correction to $7.50. The predicted short-term price is $8.9, potentially stabilizing at $8.5 over four weeks.
Biotechnology , Healthcare , Alert

Precigen, Inc.: Shah Rutul R Buys $7,019 Worth of Stock

  • Acquired: Non-Derivative
Precigen, Inc.: Shah Rutul R Buys $7,019 Worth of Stock
Shah Rutul R, the COO of Precigen, Inc., purchased stock worth $7,019 on September 26, 2025, boosting his holdings by 0.5% to 405,959 shares. Despite Precigen, Inc.'s financial struggles, including a Forward P/E of -16.5 and a 5-day average price of $3.68, Shah Rutul R shows confidence in the company's potential. Market predictions suggest a potential short-term price increase to $3.70, but challenges could drive it down to $3.20.
Biotechnology , Healthcare , Alert

Precigen, Inc.: Insider Tennant Phil Buys $21,780 Worth of Shares

  • Acquired: Non-Derivative
On September 29, 2025, Tennant Phil, Chief Commercial Officer of Precigen, Inc., acquired shares worth $21,780 on the NMS exchange. This increased his holdings by 10.16%, signaling confidence in Precigen's prospects. Despite challenges indicated by negative valuation ratios, recent trading trends show a slight upward movement, with an average price of $3.63. The stock's performance is somewhat correlated with the Nasdaq, exhibiting higher volatility. Short-term predictions suggest a price rise to $3.7, though caution is advised due to potential market volatility.
Insurance - Property & Casualty , Financial Services , After action review

Impact Of Insider Trading Signal: A Case Study On Ategrity Specialty Insurance - One Day After The Signal

  • Acquired: Non-Derivative
Impact Of Insider Trading Signal: A Case Study On Ategrity Specialty Insurance - One Day After The Signal
On September 30, 2025, an insider trading signal by Stuart J. Zimmer of Ategrity Specialty Insurance Company Holdings led to significant market activity. Zimmer's purchase of shares worth $112,064 coincided with a notable trading day on the New York Stock Exchange (NYSE). The stock opened at $19.19 and peaked at $20.105, closing at $19.85, a 3.44% increase. The highest trading volume of 7,241 shares was recorded at 12:16 PM. Zimmer's historical transactions have shown a positive return, with an annualized ROI of 3.60%.
Software - Application , Technology , After action review

Impact Of Insider Trading Signal On Ton Strategy Co - One Day After The Signal

  • Acquired: Non-Derivative
Impact Of Insider Trading Signal On Ton Strategy Co - One Day After The Signal
The insider trading activity by Stotz Manuel at TON Strategy Co involved a purchase of $485,800 worth of stock, causing a notable market reaction. Initially, the stock opened at $6.90 and reached a high of $7.44, showing a gain of 7.83%. By the end of the trading day, the price settled at $7.035, reflecting a 1.96% increase. While insider confidence initially boosted the stock, broader market trends and financial indicators suggest potential volatility, urging investors to remain cautious.
Biotechnology , Healthcare , After action review

The Ripple Effect: Insider Trading Signal'S Impact On Immuneering Corporation - One Day After The Signal

  • Acquired: Non-Derivative
The Ripple Effect: Insider Trading Signal'S Impact On Immuneering Corporation - One Day After The Signal
An insider trading signal on September 30, 2025, involved Feinberg Peter of Immuneering Corporation. He bought stock worth $33,750, boosting his stake by 3.66%. The stock opened at $6.75 and closed at $6.985, marking a 3.48% gain. The day's trading saw a peak price of $7.1 and a low of $6.3859. Trading volumes surged, with 151,116 shares at 12:31 PM, indicating strong market interest following the insider's actions. The signal was later deemed a "Win" with a 5.19% gain.
Biotechnology , Healthcare , After action review

Impact Of Insider Trading Signal: A Case Study On Precision Biosciences, Inc. - One Day After The Signal

  • Acquired: Non-Derivative
Impact Of Insider Trading Signal: A Case Study On Precision Biosciences, Inc. - One Day After The Signal
On September 30, 2025, an insider trading signal for Precision BioSciences, Inc. was identified after Frankel Stanley purchased shares worth $13,661. The stock price opened at $5.09 and peaked at $5.54, closing at $5.505, reflecting an 8.15% gain. This transaction increased Stanley's holdings by 19.18%, signaling confidence in the company's prospects. Despite positive momentum, challenges with high valuation ratios and profitability persist.

Back

Pages total: 14

Calendar